Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Financings Routine +

Liberty Defense Announces Pricing of its U.S. Initial Public Offering

Tagline: Liberty Defense Secures Nasdaq Listing Amid Valuation Reset and Capital Raise

By The Northwire Desk — AI Analysis Apr 21, 2026 · 17:18 SCAN · 7.75 Liberty Defense Holdings, Ltd.
Executive Summary
  • Liberty Defense Holdings Ltd. has priced its U.S. Initial Public Offering (IPO) to raise approximately $20 million in gross proceeds.
  • The offering includes 3,673,638 common shares at $4.50 per share and 770,807 pre-funded warrants at $4.4999 per warrant.
  • Shares are expected to begin trading on the Nasdaq Capital Market under the symbol "DETX" on April 22, 2026.
  • Common shares will cease trading on the OTCQB Venture Market (symbol LDDFF) but remain listed on the TSX Venture Exchange.
  • CEO and Director William Frain intends to purchase 5,555 common shares for approximately $25,000 in gross proceeds.
  • Underwriters hold a 30-day option to purchase up to an additional 666,666 common shares.
Material Impact
  • The IPO pricing is the culmination of the registration process announced in February 2026 (Form F-1 filing). As such, the event itself was anticipated by the market.
  • The capital raise of $20 million USD represents a significant increase over previous private placements (~C$2.6 million total in late 2025/early 2026), extending the company's runway for production scaling and contract fulfillment.
  • However, the IPO price of $4.50 is approximately 27% below the most recent OTC trading close of $6.21 (April 20, 2026). This discount suggests either weak demand at higher levels or a strategic reset to attract institutional investors on Nasdaq, which poses dilution risk for existing shareholders holding shares above this price point.
  • The move from OTCQB to Nasdaq Capital Market improves liquidity and visibility but comes with stricter compliance requirements.
  • Overall, the news is positive for long-term capital access but neutral-to-negative for short-term valuation due to the pricing discount relative to recent trading levels.
SCAN · Price
Company Overview
  • Company: Liberty Defense Holdings Ltd. develops AI-driven security screening technologies.
  • Flagship Project: HEXWAVE™ Walkthrough Screening System. Uses active millimeter-wave imaging combined with AI to detect metallic and non-metallic threats (liquids, powders, ceramics, 3D-printed weapons) contactlessly.
  • Secondary Technology: HD-AIT (High-Definition Advanced Imaging Technology) wideband upgrade kit for passenger screening, currently undergoing TSA certification testing.
  • Development Status: Commercial deployments announced in late 2025/early 2026 (JFK Airport, State Capitol, Detention Centers), indicating transition from R&D to revenue generation phase.
Read the original news release →

More from Liberty Defense Holdings, Ltd.

Jun 25, 2026 · 08:30

Next-gen millimeter-wave screening for aviation and critical infrastructure, post-IPO scaling phase.

Other May 27, 2026 · 08:30

Liberty Defense Validates HEXWAVE at LaGuardia While Settling Minor Debt; Stock Consolidates Post-IPO

Financings Apr 24, 2026 · 08:30

Liberty Defense Closes $20M Nasdaq IPO Amidst Contract Momentum and Stock Consolidation

Financings Feb 18, 2026 · 18:38

Liberty Defense lands Hexwave lab screening contract

Other Feb 18, 2026 · 08:00

Liberty Defense Secures Contract with Acclaimed Infectious Disease Laboratory for HEXWAVE(TM) Walkthrough Screening System

Production / Operations Feb 06, 2026 · 08:00

Liberty Defense Announces Public Filing of Registration Statement for Proposed U.S. Initial Public Offering

Financings